Curriculum Vitae

Richard Preston Marrs, MD

(rev. January 2008)

Education:

1962-1966 Tivy High School Kerrville, Texas
1966-1968 Schreiner Institute, Junior College Kerrville, Texas
1968-1970 University of Texas Austin, Texas, B.A.
1970-1974 University of Texas Medical Branch Galveston, Texas, M.D.
1974-1976 Residency, Obstetrics and Gynecology University of Texas Medical Branch Galveston, Texas
1976-1977 Chief Resident, Obstetrics and Gynecology University of Texas Medical Branch Galveston, Texas
1977-1979 Fellowship, Reproductive Endocrinology University of Southern California School of Medicine Los Angeles, California

Certification:

February, 1980 American Board of Obstetricians and Gynecologists
December, 1983 Sub-Specialty Boards Reproductive Endocrinology American Board of Obstetrics and Gynecology

Licensure:

1974 State of Texas
1977 State of California
2008 State of Utah

Honors and Awards

1966-1968 Academic Scholarship to Schreiner Institute
1978-1979 Jeanne Kempner Fellowship Award
10/21/79 Squibb Prize
Paper Award; Identification of PRL Secreting Pituitary Adenoma by TRH Stimulation. Pacific Coast Fertility Society
1980 Scientific Exhibit Award; Clinical and Laboratory Monitoring Methods Used in Human Menopausal Gonadotropin Therapy.
College of Obstetricians and Gynecologists Meeting
1980 Senior Residents Award for Excellence in Teaching
1982 Memorial Foundation Award Thesis;Clinical Application of Techniques Used In Human In Vitro Fertilization Research.
49th Annual Meeting of the Pacific Coast Obstetrical and Gynecological Society.
1987-1988 President—IVF Special Interest Group. SART- Chairman, Board of Directors
1998- 1999 Chairman, Academy of Assisted Reproductive Technology Professionals, Inc.
1999 – Present Who’s Who in America Professional Inc.
2000 Life Time Achievement Award- American Infertility Association
2000 - Present Best Doctor in America
2001 - Present America’s Top Doctors
2007 Distinguished Alumnus Schreiner University

Committees/Boards

1986 Chairman-In Vitro Fertilization Special Interest Group Ad Hoc Committee American Fertility Society
1985-1990 Ethics Committee American Fertility Society
1988-1994 Technical Bulletins Committee on Gynecology American College of Obstetricians and Gynecologists
1988-1992 Scientific Advisory Board-IVF Australia
1989-1991 Scientific Advisory Board-Serono Pharmaceuticals
1989-Present Physician’s Advisory Board -Resolve, Inc.
1991-1994 NCC for the Obstetric, Gynecologic and Neonatal Nursing Specialties Board
1999 – 2007 Member, Board of Directors Schreiner University

Editorial Review Boards

Member, Editorial Advisory Board, Fertility and Sterility
Journal of In Vitro Fertilization and Embryo Transfer
Journal of Clinical Endocrinology and Metabolism
American Journal of Obstetrics and Gynecology

Faculty Appointments

1977-1979 Clinical Instructor Department of Obstetrics and Gynecology Los Angeles
County-University of Southern California School of Medicine Los Angeles, California
1979-1992 Assistant Clinical Professor University of Texas Medical Branch Galveston, Texas
1979-1982 Assistant Professor Section of Endocrinology and Infertility Department of Obstetrics and Gynecology Los Angeles County-University of Southern California School of Medicine Los Angeles, California
1982-1986 Associate Professor Section of Endocrinology and Infertility Department of Obstetrics and Gynecology Los Angeles County-University of Southern California School of Medicine Los Angeles, California
1986-1988 Director Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology Cedars-Sinai Medical Center Los Angeles, California
1986-1988 Professor Department of Obstetrics and Gynecology UCLA School of Medicine Los Angeles, California
1988-1993 Director The Institute for Reproductive Research The Hospital of the Good Samaritan Los Angeles, California
1991-1995 Clinical Professor Department of OB/GYN Loma Linda University School of Medicine Loma Linda, California
1992-Mar. 2003 Director Center for Assisted Reproductive Medicine Santa Monica/UCLA Medical Center Santa Monica, California
1992-Present Managing Partner California Fertility Partners Santa Monica, California

Professional Membership

Local Los Angeles OB/GYN Society
Pacific Coast OB/GYN Society
National American College of Obstetricians and Gynecologists-Fellow Pacific Coast Fertility Society
Society for Gynecologic Investigation
Endocrine Society
Society of Assisted Reproductive Technology (SART)

Invited Lectures

February 2, 1982- Guest Speaker Los Angeles Obstetrical & Gynecological Forum Los Angeles, California
July 22, 1982- Guest Speaker Sigma Delta Chi Professional Journalism Society North Hollywood, California
September 14, 1982- Guest Speaker Los Angeles Obstetrical & Gynecological Forum Los Angeles, California
September 26-30, 1982- Memorial Foundation Award Thesis and Guest Speaker Pacific Coast Obstetrical and Gynecological Society Pebble Beach, California
October 24-26, 1982- Guest Speaker Serono Clinical Colloquia on Reproduction Carmel, California
February 22, 1983- Marlowe Guest Lecturer The Society of Obstetricians and Gynecologists of Toronto Toronto, Canada
July 5-6, 1983- Committee Member IVF Committee on Minimal Standards American Fertility Society Dallas, Texas
May 14-16, 1984- Chairman and Guest Speaker III World Congress In Vitro Fertilization and EmbryoTransfer Helsinki, Finland
August 9, 1984 Invited Witness Subcommittee on Investigations and Oversight United States House of Representatives Rep. Albert Gore, Jr., Chairman Washington, DC
September 27-29, 1984- Program Director and Guest Speaker International Conference on Human In Vitro Fertilization Montreal, Canada
August, 1985 Keynote Lecturer IV Japanese Conference on Fertility Tokyo, Japan
August, 1985 Visiting Professor Cha Women’s Hospital Seoul, Korea
August, 1985 Visiting Professor Department of OB/GYN Yonsei University College of Medicine Seoul, Korea
November 18-22, 1985 Keynote Speaker IV World Congress In Vitro Fertilization Melbourne, Australia
April 4-10, 1987 Guest Speaker V World Congress on In Vitro Fertilization Norfolk, Virginia
June 1, 1988 Member Subcommittee On Regulation and Business Opportunities Regulation of the Advanced Technologies Ad Hoc Committee United States House of Representatives, Representative Ron Wyden, Chairman Washington, DC
March 9, 1989 Invited Witness Subcommittee on Regulation and Business Opportunities Regulation of the Advanced Technologies United States House of Representatives, Representative Ron Wyden, Chairman Washington, DC
March 13, 1990 Guest Speaker Schreiner College Kerrville, Texas
October 6, 1990 Guest Speaker Jan Behrman, MD Testimonial Dinner Royal Oak, Michigan
February 18-23, 1991 Invited Advisor Epworth Hospital Infertility Medical Centre PTY. LTD Melbourne, Australia
February 7, 1992 Keynote Speaker Unihealth Seminar Universal City, California
May 20-22, 1993 Guest Speaker Assisted Reproductive Technologies, An International Symposium The Westin Hotel Chicago, Illinois
February 8-9, 1994 Guest Speaker Legislative Workshop on Health Reform American Fertility Society Washington, DC
March 9-11, 1994 Guest Speaker NCC Meeting Chicago, IL
May 2, 1994 Guest Speaker OB-GYN Rounds-Advanced Reproductive Technology-UCLA Harbor ARTs Lecture Torrance, CA
May 14, 1994 Guest Speaker Work-up of Infertile Couples RESOLVE Irvine, CA
May 20, 1994 Committee Member Assisted Reproductive Technology PACLAC Regional Meeting
July 14-17, 1994 Guest Speaker In Vitro Fertilization and Gamete Intra Fallopian Transfer Mexican Association of Gynecology, Endoscopy, Microsurgery Puerto Vallarta, Mexico
July 23-28, 1994 Guest Speaker Surrogate Carrier University of California Los Angeles Santa Barbara, CA
September 6-10, 1994 Guest Speaker Current Controversies in Reproductive Endocrinology SERONO Laboratories New Brunswick, Canada
September 24, 1994 Committee Member SART Interim Meeting American Fertility Society Palm Springs, CA
September 28-29, 1994 Guest Speaker Assisted Reproductive Technologies, How do we choose the right procedure? TAP Pharmaceutical Inc. New York, NY
November 5, 1994 Committee Member American Fertility Society Committee Meeting American Fertility Society San Antonio, TX
June 1-5, 1996 Guest Speaker Mexican Association of Laparoscopy Mexico City
November 2-7, 1996 Committee Member American Fertility Society
February 11, 1997 Guest Speaker Assisted Reproduction Technologies February 26-27, 1997 Guest Speaker Society of OB-GYN Guadalajara, Jalisco, Mexico
April 21-23, 1997 Guest Speaker Human Oocytes: From Physiology to IVF University of Bologna Bologna, Italy
June 17-20, 1997 Committee Member VII Regional Meeting-Mexican Federation of OB-GYN Society of OB-GYN, Endoscopy Mexico City
July 22-23, 1997 Guest Speaker In vitro Fertilization and Embryo Transfer-A Comprehensive Update CME Office, UCLA School of Medicine Santa Barbara, CA
October 17-21, 1997 Committee Member 21st Century Art: Embracing Change American Society Reproductive Medicine Cincinnati, OH
November 14, 1997 Guest Speaker Dilemas in Infertility California Hospital Medical Center Los Angeles, CA
December 2-5, 1997 Guest Speaker The ART: State of the ART Symposium SERONO Laboratories Hawaii, HI
July 20 –22, 1998 Guest Speaker Annual In vitro Fertilization and Embryo Transfer- A Comprehensive Update CME Office, UCLA School of Medicine Santa Barbara, CA
August 18, 1998 Guest Speaker IVF and Oocyte Quality Serono Laboratories, Inc. Oklahoma City, Oklahoma
September 16 – 20, 1998 Committee Member 65th Annual Meeting, Pacific Coast Obstetrics and Gynecology Society Pacific Coast Obstetrics and Gynecology Whistler, British Columbia
October 29 – 30, 1998 Guest Speaker VIII National Congress of OB-GYN Serono Laboratories, OB-GYN Mexican Congress Puerto Vallarta, Mexico
November 17 – 18, 1998 Guest Speaker Optimizing the Success of Intrauterine Insemination: Analysis of Outcomes of 8,648 Consecutive Cycles SERONO Laboratories – UCSF Stanford Hospital and Clinic Stanford, CA
November 19 – 20, 1998 Guest Speaker Ovarian Stimulation for In vitro Fertilization Donor Oocytes, Surrogacy and Donor Embryos SERONO- Laboratories- University of Alabama Birmingham, Alabama
March 19 –20, 1999 Guest Speaker Symposium “Implantation” Gynecology and Human Reproduction SERONO Laboratories – Mexico S.A. de C.V.-Mexico D.F.
April 23, 1999 Guest Speaker The Eighteenth Annual Health Law Symposium-Building Families Through Reproductive Technologies: Legal, Medical and Ethical Perspectives Whittier Law School Costa Mesa, California
May 16 –18, 1999 Guest Speaker Fertile Ground: Your Practice, Your Patient and Infertility The American College of OB-GYN Annual Clinical Meeting Wyeth-Ayerst Pharmaceutical Philadelphia, PA
May 28 – June 1, 1999 Guest Speaker The ART of Donor Oocytes-State of the Science in Ovulation Induction and ART Medical University of South Carolina Programs In Medicine Charleston, South Carolina
January 13, 2000 Guest Speaker Latest Advances and Success with Assisted Reproductive Technologies St. Mary’s Health Center – St. Louis University- Dept OB-GYN Ferring Pharmaceutical St. Louis, MO
January 15, 2000 Guest Speaker Evolution in Changes of Using hMG and Advantages and Disadvantages of FSH St. Mary’s Health Center- St. Louis University- Dept OB-GYN Ferring Pharmaceutical St. Louis, MO
February 5, 2000 Guest Speaker Fertility Care in the Year 2000 and Beyond The Ritz Carlton Serono Labs and MDR Pharmacies Laguna Niguel, CA
August 3-4, 2000 Guest Speaker The Art of Donor Oocytes 2000 Medical University of South Carolina Southeastern Fertility Center, P.A. Mt. Pleasant, South Carolina
September 12, 2000 Guest Speaker Fertility and Family Forum: The Latest Options in Treatment and Adoption New York Presbyterian Hospital Uris and Weill Auditorium American Infertility Association New York, NY
June 3-5, 2001 Guest Speaker The 3rd Annual Art of Donor Oocytes and Third Party Reproduction Conference Charleston Place Hotel Ferring Pharmaceuticals Charleston, South Carolina
October 22, 2001 Guest Speaker Modern Day Gonadotropins in IVF: Technology, Mixed Protocols and New Clinical Data 57th Annual Meeting of the American Society for Reproductive Medicine Orlando, Florida
October 24, 2001 Guest Speaker ART: Ovarian Stimulation Session 57th Annual Meeting of the American Society for Reproductive Medicine Orlando, Florida
January 27, 2002 Guest Speaker Advances in Fertility Treatment Phase IIIb Mixed Protocol Investigator’s Meeting The Marriot Harbor Beach Resort Ferring Pharmaceuticals Fort, Lauderdale, Florida
May 31 – June 2, 2002 Guest Speaker Ovarian Stimulation of Oocyte Donors, Including the Use of GnRH Antagonists The 4th Annual- Art of Donor Oocytes and Third Party Reproduction Conference Double Tree Guest Suites Ferring Pharmaceuticals Charleston, South Carolina
September 25 – 28, 2002 Guest Speaker Preimplantation Genetic Diagnosis, The Future of Advanced Reproductive Technologies. The American College of OB/GYN, 2002 District III Annual District Meeting Silverado Country Club and Resort Napa Valley, CA
October 5, 2002 Guest Speaker Your Guide to Getting Pregnant Los Angeles Times Health and Fitness Festival Los Angeles, CA
October 14, 2002 Guest Speaker Selecting the Optimal Ovulation Induction Protocol for the Patient Undergoing In-Vitro Fertilization: An Exchange of Ideas ASRM-58th Annual Meeting Sheraton Seattle Hotel and Towers Ferring Pharmaceuticals Seattle, Washington, D.C.
February 19 – 23, 2003 Guest Speaker ART Issues – Patient Perspective Reproductive Health North America Group Reproductive Endocrinologist Advisory Board The Phoenician Resort Serono, Inc. Scottsdale, Arizona April 23 – 27, 2003 Guest Speaker and Poster Presentation How to Stimulate the Poorly Responsive IVF Patient Evaluation of Mixed Protocols with Bravelle (hFSH) and Repronex (hMG) to Assess Clinical Efficacy (EMBRACE) In Patients (18-33 years) Undergoing In-Vitro Fertilization Pacific Coast Reproductive Society 51st Anniversary Meeting Rancho Las Palmas Resort Rancho Mirage, CA
May 17, 2003 Guest Speaker Fertility Talk-Educational Seminar The American Infertility Association Los Angeles Marriott Los Angeles, CA
June 28 – July 2, 2003 Guest Speaker LH Supplementation in ART- which Patients can benefit? Towards Optimizing Success in ART ESHERE Meeting Palacio de Congresos, Madrid Auditorium A - Europa Serono, Inc. Madrid, Spain
September 14 – 16, 2003 Guest Speaker Importance of LH in COH cycles Schreiner College Ferring Pharmaceuticals Austin, Texas
September 18 – 20, 2003 Guest Speaker Pacific Coast Obstetrical and Gynecological Society 17th Annual Meeting The American College of Obstetrics and Gynecologists Anchorage, Alaska
September 30 – October 3, 2003 Guest Speaker Ovulation Induction: Save & Effective Approaches for the Practitioner Profiles In Courage: Stimulation of the “Poor Responder” ART Patient Philadelphia Area Reproductive Endocrine Society La Buca Restorante Ferring Pharmaceuticals Philadelphia, PA
October 3, 2003 Guest Speaker Preimplantation Embryo Genetics Santa Monica College Embryology Symposium Santa Monica College Santa Monica, CA
October 11 – 15, 2003 Guest Speaker PGD- Building the Foundation for Sound Clinical Practice Mixed Protocol Study in Younger Patient Ovarian Stimulation Standard Protocols I –B American Society for Reproductive Medicine 59th Annual Meeting Ferring Pharmaceuticals San Antonio, Texas
November 16, 2003 Guest Speaker A Closer Look at Ovulation Triggering: Is It As Simple As It Seems? University of California San Francisco Journal Club Serono, Inc. San Francisco, CA
December 04, 2003 Guest Speaker Techniques for the Poor Responders Stimulation Effects on Embryo Outcome Bay Area Reproductive Society Marriott Hotel Ferring Pharmaceuticals San Francisco, CA
January 17-18, 2004 Guest Speaker Randomized trial to compare effect of recombinant human LH in women undergoing assisted reproduction treatment Serono Reproductive Health Scientific Advisory Board Meeting SERONO, Inc. Royal Palms Hotel Phoenix, AZ
May 20- 22, 2004 Guest Speaker The ART of Controlled Ovarian Stimulation 17th International Conference for Nurses in Reproductive Medicine Loews Coronado Bay Resort SERONO, Inc. San Diego, CA
May 28-30, 2004 Guest Speaker Utilization of Cryopreserved Embryos in Donor Oocyte Program 6th Annual Art of Donor Oocytes Double Tree Hotel Medical Education Resources, Inc. Charleston, SC
June 12-13, 2004 Guest Speaker Management of “Poor Responders” Total Quality Management In the IVF Program ANA Hotel SERONO, INC. Tokyo, Japan
July 27 – 28, 2004 Guest Speaker A Closer Look at Ovulation Triggering: Is it as Simple as it Seems? Serono Reproductive Health Ambassador Meeting University of California San Francisco SERONO, Inc. San Francisco, CA
October 18-20, 2004 Guest Speaker Optimizing the ART Process Now and in the Future: From Gonadotropins to Enhanced Evaluation of Embryonic Development” ASRM-60th Annual Meeting Philadelphia Marriott Hotel Ferring Pharmaceuticals Philadelphia, PA
October 21-24, 2004 Guest Speaker Embryo Fragmentation as a Determinant of Blastocyst Development in Vitro and of Pregnancy Outcomes Folloing Embryo Transfer Pacific Coast Obstetrical and Gynecological Society-71st Annual Mtg. JW Desert Ridge Resort Phoenix, AZ
July 24, 2005 Guest Speaker “Factors Affecting Ovarian Stimulation Response in ART” Reproductive Biology Tokyo Symposium Japan Toshi Center Hall Tokyo
September 8, 2005 Guest Speaker Ferring hMG Roundtable Meeting Sheraton Crossroads Mahwah, NJ
September 19, 2005 Guest Speaker Ferring hMG Roundtable Meeting O’Hare Hilton Hotel Chicago, IL
February 16, 2006 Guest Speaker / Faculty Member Recognition Banquet Schreiner University Kerrville, Texas
February 24 -26, 2006 Guest Speaker / Faculty Member “The Future of fertility Treatments” Ferring Fertility Speaker Training Meeting The Mansion on Turtle Creek Dallas, TX
March 9 -12, 2006 Guest Speaker / Faculty Member Organon’s Expert in Reproductive Medicine The Sanctuary on Camelback Scottsdale, AZ
April 12, 2006 Guest Speaker “Factors Affecting COH Outcomes in ART Cycles” Ferring Fertility Speaker Program Detroit, MI
April 26, 2006 Guest Speaker “Factors Affecting COH Outcomes in ART Cycles” Ferring Fertility Speaker Program Houston, TX
May 19 – 21, 2006 Guest Speaker “The Difficult Patient” The Midwest Reproductive Symposium Swissotel Chicago Chicago, IL
June 3, 2006 Guest Speaker / Faculty Member “Improving Patient and Center Efficiencies with Mixed Protocols” Ferring Fertility Advisory Board Palo Alto Four Seasons Hotel Palo Alto, CA
September 27, 2006 Guest Speaker “The Influence of LH Effect on Stimulation Response and Embryo Quality in IVF” New York Society of Reproductive Medicine New York, NY
September 27, 2006 Guest Speaker / Grand Rounds The Reproductive Neurophysiology During The Aging Process” Columbia University New York, NY
October 23-2006 Guest Speaker “Highly Purified Human-Derived FSH & Highly Purified hMG- is LH Beneficial” ASRM Annual Meeting Ernest M. Morial Convention Center New Orleans, Lousiana December 8 & 9, 2006 Guest Speaker / Faculty Member Ferring Speaker Training Meeting Michelangelo Hotel New York, NY
January 17, 2007 Guest Speaker / Faculty Member Ferring Fertility Speaker Program The Center for Human Reproduction Manhasset, NY
January 18, 2007 Guest Speaker / Faculty Member Ferring Fertility Speaker Program Miami Beach, FL April 21, 2007 Recognition Dinner “Distinguished Alumnus Award Schreiner University Kerrville, TX
April 23, 2007 Guest Speaker The Female Reproductive System University of Kentucky School of Nursing Kentucky, VA
April 27 – April 28, 2007 Guest Speaker “Improving Patient and Center Efficiencies with Mixed Protocols” Ferring Advisory Board Meeting Middleburg, VA
October 15, 2007 Guest Speaker “The Science Behind Luteal Support” ASRM- Annual Meeting Washington Convention Center Washington, DC
October 16, 2007 Guest Speaker “The Science Behind Luteal Support” Ferring Scientific Advisory Meeting Grand Hyatt Hotel Washington, DC
November 7, 2007 Guest Speaker “The Science Behind Luteal Support” Ferring Fertility Dinner Meeting McLean, VA
November 8, 2007 Guest Speaker “Science Behind Luteal Support” Ferring Fertility Dinner Meeting In Man Park, Atlanta, GA
December 7, 2007 Guest Speaker / Faculty Member Ferring –Prion Advisory Board Meeting The Mansion at Turtle Creek Dallas, TX

Bibliography

Peer Review Journals

1. Kletzky OA, Marrs RP, Costin G, Bernstein G, March CM, Mishell DR Jr.;Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab 48:901-905, 1979.
2. Marrs RP, Kletzky OA, Teal J, Davajan V, March CM, Mishell DR Jr.; Comparison of serum prolactin, plain radiography and hypocycloidal tomography of the sella turcica in patients with galactorrhea. Am J Obstet Gynecol 135:467-469, 1979.
3. Marrs RP, Kletzky OA, Howard WF, Mishell DR Jr.; The disappearance of human chorionic gonadotropin (hCG) and resumptionnof ovulation following abortion. Am J Obstet Gynecol 135:731-736, 1979.
4. Kletzky OA, Marrs RP, Nicoloff JT; Effects of cyproheptadine on insulin-induced hypoglycemia secretion of PRL, GH and cortisol. Clin Endocrinol 13:231-234, 1980.
5. Kletzky OA, Marrs RP, Howard WF, McCormick W, Mishell DR Jr.; Prolactin (PRL) synthesis and release during pregnancy and puerperium. Am J Obstet Gynecol 136:545-550, 1980.
6. Marrs RP, Bertolli SJ, Kletzky OA; The use of thyrotropin-releasing hormone in distinguishing prolactin-secreting pituitary adenoma. Am J Obstet Gynecol 138:620-625, 1980.
7. Jensen MR, Kaplan BJ, Marrs RP, March CM; Maturation value as an indicator of the serum estrogen concentration during treatment with gonadotropins. Acta Cytol 25:251-254, 1981.
8. Kletzky OA, Marrs RP, Rundall TT, Weiss MH, Beierle JW; Monolayer and suspension culture of human prolactin-secreting pituitary adenoma. Am J Obstet Gynecol 138:660-664, 1980.
9. Marrs RP, Kletzky OA, Mishell DR Jr.; A separate mechanism of gonadotropin recovery following pregnancy termination. J Clin Endocrinol Metab 52:545-548, 1981.
10. Marrs RP, March CM, Mishell DR Jr.; A comparison of clinical and laboratory methods in monitoring human menopausal gonadotropin therapy. Fertil Steril 34:542-547, 1980.
11. Roy S, Brenner P, Marrs RP, Mishell DR Jr.; Termination of early gestation with a single vaginal suppository of (15S)-15-methyl- prostaglandin F2a methyl ester. Contraception 22:137-152, 1980.
12. March CM, Kletzky OA, Davajan V, Teal J, Weiss M, Apuzzo MLH, Marrs RP, Mishell DR Jr.; Longitudinal evaluation of patients with untreated prolactin secreting pituitary adenomas. Am J Obstet Gynecol 139:835-844,1981.
13. Marrs RP, Kletzky OA, Mishell DR Jr.; Functional capacity of the gonadotrophs during pregnancy and the puerperium. Am J Obstet Gynecol 141:658-661, 1981.
14. Zeidler A, Gelfand R, Tamagna E, Marrs RP, Chopp R, Kletzky OA; Pituitary gonadal function in diabetic male patients with and without impotence. Andrologia 14 (1):62-68, 1982.
15. March CM, Marrs RP, Goebelsmann U, Mishell DR Jr.; Feedback of estradiol and progesterone upon gonadotropin and prolactin release. Obstet Gynecol 58:10-16, 1981.
16. Marrs RP, Brenner PF, Roy S, Mishell DR Jr.; Termination of early gestation with (15S)-I5-methyl prostaglandin F2a methyl ester vaginal suppositories. Contraception 24:617-630, 1981.
17. Vargyas JM, Marrs RP, Kletzky OA, Mishell DR Jr.; Correlation of ultrasonic measurement of ovarian follicle size and serum estradiol levels in ovulatory patients using clomiphene citrate for in vitro fertilization. Am J Obstet Gynecol 144:569-573, 1982.
18. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, Nakamura RM, diZerega GS; Characterization of porcine granulosa cells by isopycnic gradient centrifugation. Biol Reprod 27:633-640, 1982.
19. Berger T, Marrs RP, Saito H, Kletzky OA; Factors affecting human sperm penetration of zona free hamster ova. Am J Obstet Gynecol 145:397-401, 1983.
20. diZerega GS, Marrs RP, Roche PC, Campeau JD, Kling 0; Identification of protein(s) in pooled human follicular fluid which suppress follicular response to gonadotropins. J Clin Endocrinol Metab 56:35-41, 1983.
21. diZerega GS, Marrs RP, Campeau SD, Nakamura RM, Kling OA; Human granulosa cell secretion of protein(s) which suppress follicular response to gonadotropins. J Clin Endocrinol Metab 56:147-155, 1983.
22. Marrs RP, Vargyas JM, Gibbons WE, Saito H, Mishell DR Jr.; A modified technique of human in vitro fertilization and embryo transfer. Am J Obstet Gynecol 147:318-322, 1983.
23. Brenner PF, Marrs RP, Roy S, Mishell DR Jr.; Termination of early gestation with 9-dexoxo-16, 16-Dimethyl-9 methylene prostaglandin E2. Contraception 26:261-277, 1983.
24. Marrs RP, Vargyas JM, March CM; Correlation of ultrasonic measurements in human menopausal gonadotropin therapy. Am J Obstet Gynecol 145 (4):417-421, 1983.
25. Lahteenmaki P, Marrs RP, Schecter J, Zacharias S, Kletzky OA; Hormonal and morphologic effects of bromocriptine on normal rat pituitary and Gh3 tumor cells. Am J Obstet Gynecol 153:349, 1985.
26. Marrs RP, Vargyas JM, Saito H, Gibbons WE, Berger T, Mishell DR Jr.; Clinical application of techniques used in human in vitro fertilization research. Am J Obstet Gynecol 146:477-481, 1983.
27. Rossman F, d’Ablaing G III, Marrs RP; Pregnancy complicated by ruptured endometrioma. Obstet Gynecol 62:519-521, 1983.
28. Kletzky OA, Marrs RP, Davajan V; Management of patients with hyperprolactinemia and normal or abnormal tomograms. Am J Obstet Gynecol 147:528-532, 1983.
29. diZerega GS, Campeau JD, Lobo RA, Nakamura RM, Ujita EL, Marrs RP; Activity of a human follicular fluid protein(s) during normal and stimulated ovarian cycles. J Clin Endocrinol Metab 57:838-846, 1983.
30. Marrs RP, Lobo R, Campeau JD, Nakamura RM, Ujita EL, diZerega GS; Correlation of human follicular fluid inhibin activity with spontaneous and stimulated follicular development. J Clin Endo Metab 55:704-709, 1984.
31. Saito H, Berger T, Mishell DR Jr., Marrs RP; The effect of serum fractions on embryo growth. Fertil Steril 41:761-765, 1984.
32. Saito H, Berger T, Mishell DR Jr., Marrs RP; Effect of variable concentration of serum on mouse embryo development. Fertil Steril 41:460-464, 1984.
33. diZerega GS, Campeau JD, Ujita EL, Kling O, Marrs RP, Lobo R, Nakamura R; The possible role for a follicular protein(s) in the intraovarian regulation of folliculogenesis. Sem Reprod Endocrinol 1:309-322, 1983.
34. Campeau JD, Marrs RP, diZerega GS; Comparison of Chromato- focusing and isoelectric focusing for recovery of specific activity from biological fluids. J Chromatography 262:334-339, 1983.
35. Marrs RP, Saito H, Yee B, Sato F, Brown J; Effect of variation of in vitro culture techniques upon oocyte fertilization-embryo development in human in vitro fertilization procedures. Fertil Steril 41:519-523, 1984.
36. Marrs RP, Vargyas JM, Shangold GM, Yee B; The effect of the time of initiation of clomiphene citrate on multiple follicle development for human in vitro fertilization and embryo replacement procedures. Fertil Steril 41:682- 685, 1984.
37. Weimer SL, Campeau JD, Marrs RP, diZerega GS; Alternation of human follicular fluid plasminogen activator activity by ovarian hyperstimulation. J In Vitro Fertiliz Embryo Transfer 1:263-266, 1984.
38. Shangold GA, Kletzky OA, Marrs RP, Mishell DR Jr.; Hyperprolactinemia: Comparison of thyrotropic-releasing hormone and tomography. Obstet Gynecol 63:771, 1984.
39. Vargyas JM, Morente C, Shangold G, Marrs RP; The effect of different methods of ovarian stimulation for human in vitro fertilization and embryo transfer. Fertil Steril 42:745-749, 1984.
40. Sueldo C, Marrs RP, Berger T, Kletzky OA, O'Brien T; Correlation of semen transferrin concentration and sperm fertilizing capacity. Am J Obstet Gynecol 150:528-530, 1984.
41. diZerega GS, Marrs RP, Lobo R, Ujita EL, Brown J, Campeau JD; Correlation of inhibin and follicle regulatory protein activities with follicular fluid steroid levels in anovulatory patients. Fertil Steril 41:849-855, 1984.
42. Berger T, Marrs RP, Moyer DL; Comparison of techniques for selection of motile spermatozoa. Fertil Steril 43:268-273, 1985.
43. Serafini P, Yee B, Vargyas JM, Marrs RP; Development of multiple ovarian follicles for in vitro fertilization in a patient with an undiagnosed ectopic pregnancy. Fertil Steril 43:656-658, 1985.
44. Sueldo CE, Berger T, Kletzky OA, Marrs RP; Seminal prolactin concentration and sperm reproductive capacity. Fertil Steril 43:632 -635, 1985.
45. Marrs RP, Vargyas JM, Hoffman D, Yee B; Use of various ovarian stimulation methods to improve oocyte and embryo production for human in vitro fertilization. Annuals of the New York Academy of Science 442:112- 118, 1985.
46. Battin D, Vargyas JM, Sato F, Brown J, Marrs RP; The correlation between in vitro fertilization of human oocytes and semen profile. Fertil Steril 44:835-838, 1985.
47. Lobo RA, diZerega GS, Marrs RP; Follicular fluid steroid levels in dysmature and mature follicles from spontaneous and hyperstimulated cycles in normal and anovulatory women. J Clin Endo Metab, 60 (1):81-87, 1985.
48. Serafini P, Marrs RP; Computerized staged-freezing techniquesimproves sperm survival and preserves penetration of zona-free hamster ova. Fertil Steril 45:854-858, 1986.
49. Marrs RP, Lobo R, Campeau JD, Nakamura RM, Brown J, Ujita EL, diZerega GS; Correlation of human follicular fluid inhibin activity with spontaneous and induced follicle maturation. J Clin Endo Metab 58:704-709, 1984.
50. Cha YK, Barnes R, Marrs RP, Lobo RA; Correlation of the bioactivity of LH in follicular fluid with oocyte maturity in the spontaneous cycle. Fertil Steril 45:338-341, 1986.
51. Vargyas JM, Kletzky OA, Marrs RP; The effect of laparoscopic follicular aspiration on ovarian steroidogenesis during the early preimplantation period. Fertil Steril 45:221, 1986.
52. Sato F, Marrs RP; The effect of PMSG on mouse embryos fertilized in vivo or in vitro. J In Vitro Fertil & Embryo Transfer 3:353-357, 1986.
53. Serafini P, Hauser D, Moyer D, Marrs RP; Ultrastructural sperm head configuration: correlation with motility and capacity to penetrate zona-freehamster ova before and after freezing. Fertil Steril 46:691, 1986.
54. Serafini P, Hauser D, Moyer D, Marrs RP; Cryopreservation of human spermatozoa: Correlations of ultrastructural sperm head configuration with sperm motility and ability to penetrate zona-free hamster ova. Fertil Steril 46:691, 1986.
55. Paulson RJ, Bernstein GS, Marrs RP, Lobo RA; Idiopathic oligospermia and peripheral androgen metabolism. Fertil Steril 46:400, 1987.
56. Serafini P, Marrs RP; Human pre-ovulatory serum (POS) enhances the efficiency of sperm cryopreservation. Fertil Steril, 1987.
56. Ogawa T, Marrs RP; The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 47:156-161, 1987.
57. Ogawa T, Ono T, Marrs RP; The effect of serum fractions on single-cell mouse embryos in vitro. Fertil Steril 4:153-158, 1987.
58. Vargyas JM, Marrs RP; Endogenous luteinizing hormone (LH) release using human menopausal gonadotropins (HMG) for in vitro fertilization.(IVF) J IVF-ET, 4:107-111, 1987.
59. Yee B, Barnes R, Vargyas JM, Marrs RP; Correlation of transvaginal ultrasound measurements with follicle number and volume at laparoscopy for in vitro fertilization. Fertil Steril 5:828-832, 1987.
60. Marrs RP, Brown J, Sato F, Ogawa T, Yee B, Paulson R, Serafini P, Vargyas JM; Successful pregnancies from cryopreserved human embryos produced by in vitro fertilization. Am J Obstet Gynecol 156:1503-1508, 1987.
61. Serafini P, Kerin J, Marrs RP; Management of unexpected dermoid cyst during laparoscopy for oocyte pick-up (OPU). Fertil Steril 48, 1987.
62. Ogawa T, Marrs RP; The effect of protein supplementation on single-cell mouse embryos in vitro. Fertil Steril 47:156-161, 1987.
63. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; An alternative approach to controlled ovarian hyperstimulation (COH) in "poor responders": Pretreatment with a GnRh analog (GnRHa). Fertil Steril 49(1):90-95, 1988.
64. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; Occurrence of a spontaneous luteinizing hormone (LH) surge in superovulated cycles- predictive value of serum progesterone (P). Fertil Steril 49 (l):86-89, 1988.
65. Serafini P, Stone BA, Kerin J, Batzofin J, Quinn P, Marrs RP; Spontaneous LH surge in women undergoing controlled ovarian hyperstimulation (COH) -critical analysis of monitoring parameters. Fertil Steril 49:95, 1988.
66. Stone BA, Vargyas JM, Marrs RP, Quinn PJ, Kerin J, Batzofin J, Tan T, Serafini P; Levels of steroid and protein hormones in antral fluids of women treated with FSH, hMG, clomiphene citrate/hMG, or with hMG/FSH following pituitary down-regulation with a GnRH analog. Fertil Steril 49(2):249-257, 1988.
67. Stone BA, Vargyas JM, Marrs RP, Quinn P, Batzofin J, Tan T, Kerin J, Serafini P; Levels of steroid and protein hormones in antral fluid of women treated with different combinations of gonadotropins, clomiphene citrate and a gonadotropin releasing hormone analog. Fertil Steril 49 (2):249-257, 1988.
68. Stone BA, Tan T, Koopersmith TB, Quinn K, Marrs RP; Luteotropic activity in serum of women following embryo transfer in a program of in vitro fertilization. JIVFET: 5 (5) :102-109,1988.
69. Serafini P, Batzofin J, Kerin J, Marrs RP; Pregnancy--A risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation. Fertil Steril 50:371-372, 1988.
70. Kerin J, Quinn P, Stone BA, Serafini P, Batzofin J, McAllister J, Reading A D'Amico, Wade M, Marrs RP; The way forward for in vitro fertilization. Jour of Repro and Fertil Supplement 36:161-172, 1988.
71. Stone BA, Serafini P, Quinn K, Quinn P, Kerin J, Marrs RP; Serum levels of gonadotropins and estradiol during ovarian hyperstimulation in women treated with leuprolide acetate. Obstet and Gynecol 73 (6):990-995, June, 1989.
72. Quinn P, Stone BA, Marrs RP; Suboptimal laboratory conditions can affect pregnancy outcome following embryo transfer on Day 1 or 2 after insemination in vitro. Fertil Steril, 53, 168-170, 1989.
73. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Tailoring a commercial radioimmunoassay to the range of levels of progesterone occurring in human serum during ovarian hyperstimulation and following embryo/gamete transfer. J of in Vitro Fertil and Embryo Trans., 1989. 6(4), 257-260. Chicago, IL.
74. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Responses of patients to different lots of human menopausal gonadotropins during ovarian hyperstimulation. Fertil Steril. 52:5, 745-752, 1989.
75. Stone BA, Koopersmith T, Quinn K, Quinn P, Marrs RP; Levels of interleukin-2 receptor in serum of patients during the menstrual cycle and following embryo/gamete transfer. J of Repro Immuno 20: 1989.
76. Stone BA, Quinn K, Quinn P, Vargyas JM, Marrs RP; Tailoring a commercial radioimmunoassay to the range of levels of progesterone occurring in human serum during ovarian hyperstimulation and following embryo/gamete transfer. J of In Vitro Fertil 6 (4):257-260, 1989.
77. Stone BA, Quinn K, Tonetta SA, Quinn P, diZerega GS, Marrs RP; Levels of follicle-stimulating hormone, prolactin, estradiol and follicle-regulatory protein in antral fluids of patients treated with leuprolide acetate. Fertil Steril.
78. Tonetta SA, Stone BA, Marrs RP, diZerega GS; Concentrations of follicle regulatory protein, steroids and gonadotropins in antral fluids from women stimulated with metrodin and hCG. J Reprod Fert 88:389-397, 1990.
79. Richards DW, Quinn P, Stone BA, Marrs RP; Effect of human follicular fluids from pregnant and nonpregnant patients on the development of mouse zygotes in vitro. J In Vitro Fertil 7 (l):22-27, 1990.
80. Anderson RE, Serafini PC, Paulson RJ, Sauer MV, Marrs RP; Detection and management of pathological, non-palpable, cystic adnexal masses. Human Repro 5 (3):279-281, 1990.
81. Stone BA, Marrs RP; Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstim¬ulation. Fertil Steril 56:52-58, 1991.
82. Marrs RP; The use of potassium - titanyl - phosphate (KTP/532) laser for laparoscopic removal of ovarian endometrioma. Am J OB/GYN 164:1622-8, 1991.
83. Stone BA, Marrs RP; Ovarian responses to menopausal gonadotropins in groups of patients with differing basal growth hormone levels. Fertil Steril 58 (1):32-36, 1992.
84. Stone BA, Marrs RP; Levels of growth hormone and insulin-like growth factor-1 in serum of women during early pregnancy. Infertility, 15 (2), 114-131.
85. Rector NA, Markusen TE, Stone BA, Marrs RP; Numbers and quality of oocytes following induction of multiple folliculogenesis in women and in mice with different lots of human menopausal gonadotropins (hMG). Fertil Steril 60 (6): 1082-1087, 1993.
86. Marrs RP, Ringler GE, Stein AL, Vargyas JM, Stone BA; The use of surrogate gestational carriers for assisted reproductive technologies. Am J Obstet Gynecol, 1993.
87. Hirayama T, Quinn P, Marrs RP; Assessment of sister chromotid exchange in mouse embryos produced by microsurgical fertilization. Mole Repro & Develop
88. Karlin BY, Marrs RP, Legasse LD; Advanced stage ovarian carcinoma presenting during infertility evaluation. Am J Obstet Gynecol, 1994.
89. Heiner J, Nazarian D, Stone BA, Marrs RP. Early prediction of invitro fertilization (IVF) pregnancy outcome refined: The value of simultaneously drawn estradiol (E2) levels when the initial human chorionic goandotropin (hCG) result is low. Proceedings of the American Fertility Society, 1994, Submitted.
90. Stone BA, Vargyas JM, Ringler GE, Stein AL, Marrs RM, Determinants of the outcome of intrauterine insemination: Analysis of outcomes of 9963 consecutive cycles. Am J. Obstet Gynecol, June 1999.
91. Marrs RM, Greene J, Stone BA, Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos. Am J. Obstet Gynecol, 2004.
92. Keye N, Marrs RM, Check J, et al., Evaluation of mixed protocols with Bravelle (human derived FSH) and Repronex (hMG) to access clinical efficacy (EMBRACE) in women undergoing in vitro fertilization. Fertil Steril 82, 348-357, 2004.
93. Marrs RM, Meldrum D, Mansher E, et al., Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod. Biomed. Online, 8, 175-182, 2004.
94. Stone BA, Greene H, Vargyas JM, Ringler GE, Marrs RM, Embryo fragmentation as a determinant of blastocyst development in vitro and pregnancy outcomes following embryo transfer. Amer. Journal OB/GYN, 192, 2014-2020, 2005.
95. Hatoum H, Keye W, Marrs RM, Walton S, Marshall D. A Markov model of the cost effectiveness of human-derived follicle stimulating hormone (FSH) versus recombinant FSH using comparative clinical trail date. Fertil. Steril 83, 804-807, 2005.

Non-Peer Review Journals

1. Lahteenmaki P, Lobo R, Marrs RP, Gibbons WE, Nakamura RM, diZerega GS; Granulosa cells heterogeneity in women treated with clomiphene and human chorionic gonadotropin. Proceedings in the IV Ovarian Workshop . G. Greenwald and P. Terranova (eds). Raven Press, 1982.
2. diZerega GS, Kling OA, Marrs RP, Montz F, Goebelsmann U, Nakamura RM; Intraovarian regulation of follicle selection: Identification of a follicular fluid protein inhibitor in porcine and human follicular fluid. Proceedings IV Ovarian Workshop . G. Greenwald and P. Terranova (eds). Raven Press, New York, 1982.
3. Lahteenmaki P, Lobo R, Marrs RP, Gibbons W, Nakamura R, diZerega G; Characterization of isopycnic gradient centrifugation of granulosa cells from women treated with clomiphene and hCG. Proceedings IV Ovarian Workshop. G. Greenwald and P. Terranova (eds). Raven Press, New York, 1982.
4. Marrs RP; Clinical experience of in vitro fertilization. Proceedings from Serono Colloquia on Reproduction. No. 4, Carmel, California, October, 1982.
5. Marrs RP; Special issue on the proceedings of the In Vitro Fertilization Workshop. Infertility Vol. #6, No. 1-4, 1983. Anibal Acosta (ed). Marcel Dekker Inc., New York.
6. Marrs RP; Media Preparation and Quality control. Special issue on the proceedings of the In Vitro Fertilization Workshop. Infertility Vol. #5, No. 1-4, 1983. Anibal Acosta (ed). Marcel Dekker Inc. New York.
7. Marrs RP, Girtanner RL; The use of min dose heparin in pelvic surgery. Texas Medicine 73:54, 1977.
8. Marrs RP, Mishell DR Jr.; Placental Trophic Hormones in Symposium. Clinical Obstetrics and Gynecology 1980, Ronald Chez (ed). Harper and Row, Hagerstown, Maryland, Vol. 23, No. 3.
9. Marrs RP; The reality of the 80's--human in vitro fertilization. Cont. OB/GYN. August, 1982.
10. Marrs RP; Human in vitro fertilization and embryo transfer. Obstetrics and Gynecology epitomes in The Western Journal of Medicine. October, 1983.
11. Marrs RP, Schulman JD; Historical and Practical Aspects of In Vitro Fertilization. Gynecology and Obstetrics, 1984. J. Sciarra (ed). Harper and Row, Philadelphia, PA.
12. Marrs RP, Vargyas JM, Gibbons WE, Saito H, Yee B, Sueldo C, Kletzky OA; The Effect of Initiation of Ovulatory Stimulation and Preincubation Interval on Human In Vitro Fertilization Outcome. Clinica Obstetrica E. Ginecologica IV. Ed Crosignani. Academic Press, London, 1983.
13. Marrs RP; Human In Vitro Fertilization. Management of Common Problems in Obstetrics and Gynecology. Daniel R. Mishell and Paul R. Brenner (eds). Medical Economics Books, New Jersey. 1983.
14. Marrs RP, Vargyas JM, Berger T; Human In Vitro Fertilization. An Answer to Male Infertility? Seminars in Urology. E. Darracott Vaughan Jr., (eds). Grune & Stratton, New York. 1984.
15. Marrs RP, Vargyas JM; Effects of ovarian stimulation on in vitro fertilization in the human. In Bio Chemistry of the Reproductive Years. Proceedings of the 7th O. Beckman Conference in Clinical chemistry. Page 227-236. Editor Paige K. Besch. J Am Assn for Clin Chem, publishers, Winston-Salem, North Carolina. 1984
16. Marrs RP; Oocytes: From Development to Fertilization. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986
17. Marrs RP, Vargyas JM; Human In Vitro Fertilization--State of the Art. In Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
18. Marrs RP; Tubal Surgery. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
19. Marrs RP, Vargyas JM; Pelvic Endometriosis. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
20. Mishell DR Jr., Marrs RP; Endocrinology of Lactation and the Puerperium. Infertility, Contraception and Reproductive Endocrinology, Second Edition. Davajan and Mishell, editors. Medical Economics Books, Oradell, New Jersey. 1986.
21. Marrs RP; Laboratory conditions for human in vitro fertilization procedures. Clinical Obstet Gynecol 29 (1)180-189, 1986.
22. Yee B., Marrs RP; Cryopreservation of human embryos, the latest in vitro fertilization technique. Medical Aspects of Human Sexuality.
23. Marrs RP; Evaluation of the Infertile Female. Reproductive Failure. Editor Alan H. Decherney. Churchill Livingston, Inc. New York.
24. Paulson R, Marrs RP; Biotechnologic advances and infertility. The Female Patient. Vol. 2: No. 2, February 1986.
25. Marrs RP; Embryo Culture and Transfer. Gynecology and Obstetrics. Vol. 5, Chap. 98. L.B. Lippincott Company, Philadelphia, Pennsylvania.
26. Marrs RP; Use of antiestrogens for multiple follicle development in human in vitro fertilization. New York Academy of Sciences.
27. Paulson RJ, Marrs RP; Ovulation stimulation and monitoring for in vitro fertilization. Current Problems in Obstet Gynecol & Fertility. Yearbook Publishers, Chicago, IL.
28. Marrs RP, Serafini P, Kerin J; Monitoring Ovulation. Advances in Fertility and Sterility. Vol. 1, pp. 25-31. Parthenon Publishing Group, UK.
29. Batzofin JH, Marrs RP, Serafini P, Lipschultz LI; Assisted reproductive treatments for male factor infertility. Problems in Urology, 1 (3):430-442, 1987.
30. Marrs RP, Stone BA, Serafini PC, Quinn PJ, Reading AE, Batzofin J, Kerin J; Frontiers of Reproductive Research. Chapter 8. For Biological Applications Program, Office of Technology Assessment (OTA), Congress of the United States, Washington, DC. 1987.
31. Marrs RP; The use of ultrasound in Reproductive Medicine. Women's Wellness Newspaper. B.C. Decker, Inc., Burlington, Ontario, Canada. 1988.
32. Marrs RP, Serafini P, Kerin J, Batzifin J, Stone BA, Brown J, Wilson L, Quinn P; Methods used to improve gamete efficiency. In Vitro Fertilization and Other Assisted Reproduction. Annals of the New York Academy of Sciences, Vol. 541, October 31, 1988, pp. 31O-3l6. 1988.
33. Marrs RP; Cryopreservation of Ova and Embryos. Current Therapy of Infertility--2, Philadelphia, PA, 1987.
34. Marrs RP; Gamete and embryo cryopreservation techniques and results. Problems in Reproductive Endocrinology and Infertility, Elsevier, New York, NY, 1989.
35. Stangel JJ, Marrs RP, Wood C; Assisted Reproduction. ACOG Update, Medical Information Systems, Inc., Port Washington, New York, 1990.
36. Stone BA, Marrs RP; Growth hormone in serum of women during the menstrual cycle and during controlled ovarian hyperstimulation. Fertility and Sterility 56, 52-58, 1991.
37. Stone BA, Marrs RP: Levels of growth hormone, insulin-like growth factor-1 (IGF-1) and IGF-binding protein 3 in serum of women during early pregnancy. Infertility 15 (2), 114-131, 1992.
38. Stone BA, Marrs RP; Endocrinology of the Luteal Phase. International Conference on the Assisted Reproductive Technologies, The Hospital of the Good Samaritan, Los Angeles, CA, Serono Symposia, USA, pp. 123-131, 1992.
39. Stone BA, Marrs RP; Ovarian responses to menopausal gonadotropins In groups of patients with differing basal growth hormone levels. Fertility and Sterility 58, (1), 32-36, 1992.
40. Rector NA, Markusen TE, Stone BA, and Marrs RP; Numbers and quality of oocytes following induction of multiple folliculogenesis in women and in mice with different lots of human menopausal gonadotropins (hMG). Fertility and Sterility 60 (6), 1082-1087, 1993.
41. Marrs RP; Surrogate IVF. Infertility and Reproductive Medicine of North America, W.B. Saunders CO, 1993.
42. Marrs RP: Gamete Intrafallopian Transfer. Infertility and Reproductive Medicine of North America, W.B. Saunders Co., 1993.
43. Marrs RP, Stone BA, Vargyas JM, Ringler GE and Stein AL; Determinants of the outcome of intrauterine insemination (IUI); Analysis of outcomes of 9,963 consecutive cycles. American Journal of OB-GYN. 180 (6), 1524-1534, 1999.
44. Marrs RP, Vargyas JM, Ringler GE, Stone BA and Greene, J; Embryo fragmentation as a determinant of blastocyst development in vitro and pregnancy outcomes following embryo transfer. American Journal of Obstetrics and Gynecology, 192: 2014 -2020, 2005.
45. Marrs RP, Vargyas JM, Ringler GE, Stone BA and March CM. The rate at which serum total B-subunit human chorionic gonadotropin rises after embryo transfer is a predictor of the viability of pregnancy and an identifier of determinants of pregnancy. Fertility and Sterility 86 (6): 1626-1633.